 |
Platinum Wire |
Pt 7440-06-4 |
| Product |
Product Code |
Order or Specifications |
99%
Platinum Wire |
|
 |
99.9%
Platinum Wire |
|
 |
99.99% Platinum Wire |
|
 |
99.999% Platinum Wire |
|
 |
|
American Elements specializes in producing high purity uniform shaped Platinum Wire with the highest possible density for use in semiconductor, Chemical Vapor Deposition (CVD) and Physical Vapor Deposition (PVD) processes including Thermal and Electron Beam (E-Beam) Evaporation, Low Temperature Organic Evaporation, Atomic Layer Deposition (ALD), Metallic-Organic and Chemical Vapor Deposition (MOCVD). Our standard Metal Wire sizes range from 0.75 mm to 1 mm to 2 mm diameter with strict tolerances (See ASTM requirements) and alpha values (conductive resistance) for uses such as gas detection and thermometry tolerances (Also see Nanoparticles) . Please contact us to fabricate custom wire alloys and gauge sizes. Materials are produced using crystallization, solid state and other ultra high purification processes such as sublimation. American Elements specializes in producing custom compositions for commercial and research applications and for new proprietary technologies. American Elements also casts any of the rare earth metals and most other advanced materials into rod, bar or plate form, as well as other machined shapes and through other processes such as nanoparticles (See also application discussion at Nanotechnology Information and at Quantum Dots) and in the form of solutions and organometallics. We can also provide Rod outside this range. See research below. We also produce Platinum as powder, ingot, pieces, pellets, disc, granules and in compound forms, such as oxide. Other shapes are available by request.
Platinum is a Block D, Group 10, Period 6 element. The electronic configuration is Xe] 4f14 5d9 6s1. In its elemental form platinum's CAS number is 7439-88-5. The platinum atom has a radius of 137.3.pm and it's Van der Waals radius is 172.pm.
|
| Formula |
CAS No. |
Appearance |
Molecular Weight |
| Pt |
7440-06-4 |
Gray |
195.08 |
|
|
© 2001-2007. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
|
Recent Research & Development for Platinum
-
Matrix Metalloproteinase-9 May Play a Role in Recanalization and Recurrence after Therapeutic Embolization of Aneurysms or Arteries.
J Vasc Interv Radiol. 2007 Oct;18(10):1271-1279.
- Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
Gynecol Oncol. 2007 Oct 1; [Epub ahead of print]
- Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.
Cancer Chemother Pharmacol. 2008 Jan;61(1):33-38. Epub 2007 Mar 20.
- Endovascular treatment of basilar and ICA termination aneurysms: effects of the use of HydroCoils on treatment stability in a subgroup of patients prone to a higher recurrence rate.
Neuroradiology. 2007 Oct 2; [Epub ahead of print]
- Synthesis, structures and properties of a new series of platinum-diimine-dithiolate complexes.
Dalton Trans. 2007 Oct 21;(39):4446-56. Epub 2007 Aug 9.
- The first example of a Pt[dot dot dot]Pt interaction in platinum(ii) complexes bearing bulky tri-tert-butyl-2,2':6',2''-terpyridine pendants via conformational control of the calix[4]arene moiety.
Dalton Trans. 2007 Oct 21;(39):4386-9. Epub 2007 Sep 6.
- Irinotecan-Cisplatin Therapy for Patients with Extensive-Stage Small Cell Lung Cancer: Use Patterns among American Medical Oncologists 2000-2006.
J Thorac Oncol. 2007 Oct;2(10):953-956.
- Comparison of Docetaxel- and Vinca Alkaloid-Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials.
J Thorac Oncol. 2007 Oct;2(10):939-946.
- Docetaxel and Exisulind in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Multicenter, Phase II Clinical Trial.
J Thorac Oncol. 2007 Oct;2(10):933-938.
- ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer.
J Thorac Oncol. 2007 Oct;2(10):902-906
- Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model.
J Cancer Res Clin Oncol. 2007 Jan 24; [Epub ahead of print]
- Revision stapes surgery.
Adv Otorhinolaryngol. 2007;65:314-9.
- Revision stapes surgery - retrospective analysis of surgical findings in a series of 21 otosclerosis patients.
Adv Otorhinolaryngol. 2007;65:273-7.
- The crimping problem in stapes surgery.
Adv Otorhinolaryngol. 2007;65:202-5.
- Autogenic and xenogenic materials in stapes surgery - retrospective analysis of 350 cases.
Adv Otorhinolaryngol. 2007;65:179-83.
- Evolution of Stapedectomy Prostheses over Time.
Adv Otorhinolaryngol. 2007;65:174-8.
- The influence of the footplate-perilymph interface on postoperative bone conduction.
Adv Otorhinolaryngol. 2007;65:155-7.
- Photoreversible multiple additions of hydrogen to a highly unsaturated platinum-rhenium cluster complex.
J Am Chem Soc. 2007 Jan 31;129(4):986-1000.
- A mediator-free amperometric hydrogen peroxide biosensor based on HRP immobilized on a nano-Au/poly 2,6-pyridinediamine-coated electrode.
Bioprocess Biosyst Eng. 2007 Jan 23; [Epub ahead of print]
- Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Br J Cancer. 2007 Jan 29;96(2):306-13.
|
|